- Home
- OBIO vs CFBK Comparison
OBIO vs CFBK Comparison
Compare OBIO & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- CFBK
- Stock Information
- Founded
- OBIO 2017
- CFBK 1892
- Country
- OBIO United States
- CFBK United States
- Employees
- OBIO N/A
- CFBK N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- CFBK Major Banks
- Sector
- OBIO Health Care
- CFBK Finance
- Exchange
- OBIO Nasdaq
- CFBK Nasdaq
- Market Cap
- OBIO 146.2M
- CFBK 159.5M
- IPO Year
- OBIO N/A
- CFBK 1998
- Fundamental
- Price
- OBIO $2.74
- CFBK $24.00
- Analyst Decision
- OBIO Strong Buy
- CFBK Buy
- Analyst Count
- OBIO 4
- CFBK 1
- Target Price
- OBIO $14.00
- CFBK $29.00
- AVG Volume (30 Days)
- OBIO 227.6K
- CFBK 33.4K
- Earning Date
- OBIO 11-11-2025
- CFBK 10-29-2025
- Dividend Yield
- OBIO N/A
- CFBK 1.34%
- EPS Growth
- OBIO N/A
- CFBK 36.66
- EPS
- OBIO N/A
- CFBK 2.77
- Revenue
- OBIO $2,944,000.00
- CFBK $52,793,000.00
- Revenue This Year
- OBIO $29.26
- CFBK $39.98
- Revenue Next Year
- OBIO $10.65
- CFBK $10.47
- P/E Ratio
- OBIO N/A
- CFBK $8.65
- Revenue Growth
- OBIO 41.61
- CFBK 20.91
- 52 Week Low
- OBIO $2.20
- CFBK $19.23
- 52 Week High
- OBIO $6.50
- CFBK $31.17
- Technical
- Relative Strength Index (RSI)
- OBIO 59.98
- CFBK 41.96
- Support Level
- OBIO $2.20
- CFBK $23.65
- Resistance Level
- OBIO $2.89
- CFBK $24.44
- Average True Range (ATR)
- OBIO 0.14
- CFBK 0.38
- MACD
- OBIO 0.04
- CFBK -0.08
- Stochastic Oscillator
- OBIO 78.26
- CFBK 23.65
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.